Peter Webborn

 Peter Webborn
Peter Webborn
DSM Director Pharmacokinetics and MS Imaging
AstraZeneca R&D

Presentations at Drug Discovery 2015

Thu3  Sep03:00pm(30 mins)
Mass Spectrometry Imaging in Drug Discovery – Bridging Between Cells and Tissues

Session: Phenotypic Discovery & Cell Imaging
Room: To be announced

Profile of Peter Webborn

Pete Webborn has over 20 years of experience of drug discovery in the pharmaceutical industry. He has worked in the UK, US and Sweden. His particular areas on interest include prediction of PK properties from in vitro data, physicochemical properties as determinants of PK parameters and hepatic uptake transporters as modulators of drug disposition. He obtained his PhD from the University of Wales, Cardiff and is currently leading the Pharmacokinetics and Mass Spectrometry Imaging group at AstraZeneca. He was a recipient of the Royal Society of Chemistry, Malcolm Campbell medal in 2013 for his work on the discovery of Brilinta.
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018